Get the Stockscreener App
22.42
0.04%
0.01
After Hours:
22.42
Innoviva Inc stock is traded at $22.42, with a volume of 466.64K.
It is up +0.04% in the last 24 hours and down -0.27% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$22.41
Open:
$22.27
24h Volume:
466.64K
Relative Volume:
0.59
Market Cap:
$1.66B
Revenue:
$425.13M
Net Income/Loss:
$271.17M
P/E Ratio:
7.3381
EPS:
3.0553
Net Cash Flow:
$195.80M
1W Performance:
-1.36%
1M Performance:
-0.27%
6M Performance:
+15.39%
1Y Performance:
+27.17%
1-Day Range:
$22.14
$22.42
1-Week Range:
$21.70
$22.71
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
22.42 | 1.66B | 425.13M | 271.17M | 195.80M | 3.0553 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.38 | 126.81B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
774.66 | 81.62B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.09 | 45.97B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.43 | 42.76B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
298.91 | 33.88B | 5.36B | 287.73M | 924.18M | 2.5229 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations - simplywall.st
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report - Business Wire
Day Trade: Is Innoviva Inc a stock for growth or value investorsMarket Volume Report & Fast Gain Swing Alerts - baoquankhu1.vn
(INVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Quantbot Technologies LP Lowers Stake in Innoviva, Inc. $INVA - MarketBeat
American Century Companies Inc. Buys 284,253 Shares of Innoviva, Inc. $INVA - MarketBeat
Portfolio Shifts: Whats the RSI of Innoviva Inc stockProfit Target & Capital Efficient Trade Techniques - baoquankhu1.vn
Analysts Offer Predictions for Innoviva FY2027 Earnings - MarketBeat
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion - simplywall.st
Vanguard Group Inc. Sells 81,916 Shares of Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Shares Bought by Royce & Associates LP - MarketBeat
HC Wainwright Has Bearish Forecast for Innoviva Q1 Earnings - MarketBeat
CVRX,INVA Dividends - Finviz
Innoviva, Inc. (INVA) Stock Analysis: With A 45% Potential Upside, Is It Time To Buy? - DirectorsTalk Interviews
Profit Recap: Will Innoviva Inc benefit from current market trendsTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Innoviva’s 2025 Earnings and NUZOLVENCE Launch Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
INVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
INVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31Here's Why - Bitget
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why - Insider Monkey
Is It Time To Reassess Innoviva (INVA) After Its Strong Multi Year Share Price Run - Yahoo Finance
Is It Too Late To Consider Innoviva (INVA) After Its Strong Multi‑Year Share Price Run? - simplywall.st
Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives - Sahm
Innoviva CEO Details 3-Part Growth Plan, $125M Buyback, and 2026 Catalysts at Oppenheimer Conference - MarketBeat
Innoviva, Inc. (INVA): A Bull Case Theory - Yahoo Finance
Wall Street Recap: Whats the profit margin of Knowles CorporationMarket Risk Analysis & High Conviction Buy Zone Alerts - baoquankhu1.vn
Innoviva, Inc. Hits New 52-Week High at $24.25, Showcasing Strong Growth - Markets Mojo
Cantor Fitzgerald Maintains Overweight on INVA Innoviva, Inc Feb 26 2026 - Meyka
Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Innoviva earnings beat by $1.37, revenue topped estimates - Investing.com Canada
Innoviva's (INVA) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Innoviva stock hits 52-week high at 24.02 USD By Investing.com - Investing.com Australia
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results, Beats Estimates By $1.60 EPS - MarketBeat
Innoviva Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Innoviva: Fourth Quarter Earnings Overview - Bitget
Earnings Flash (INVA) Innoviva, Inc. Reports Q4 Revenue $114.6M, vs. FactSet Est of $102.6M - marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress - Business Wire
Innoviva stock hits 52-week high at 24.02 USD - Investing.com
Innoviva (NASDAQ:INVA) Reaches New 52-Week HighHere's What Happened - MarketBeat
Earnings Beat: Should I invest in Innoviva Inc before earningsJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
(INVA) Risk Channels and Responsive Allocation - Stock Traders Daily
Innoviva Reports Q4 Earnings - National Today
Innoviva, Inc. (INVA) Stock Analysis: Exploring A 40.97% Potential Upside For Investors - DirectorsTalk Interviews
Innoviva (INVA) CFO has 1,244 shares withheld for equity tax obligations - Stock Titan
Innoviva (INVA) CEO has shares withheld to cover equity vesting taxes - Stock Titan
First Week of April 17th Options Trading For Innoviva (INVA) - Nasdaq
Public Sector Pension Investment Board Increases Holdings in Innoviva, Inc. $INVA - MarketBeat
MSN Money - MSN
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - BioSpace
BTIG Research Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):